Literature DB >> 11899157

Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.

M Leverkus1, K Bhol, Y Hirako, H Pas, C Sitaru, G Baier, E B Bröcker, M F Jonkman, A R Ahmed, D Zillikens.   

Abstract

Cicatricial pemphigoid is a heterogeneous group of autoimmune subepidermal blistering diseases associated most commonly with autoantibodies to bullous pemphigoid (BP)180 and less frequently with those to laminin 5 or type VII collagen. In addition, a few cases have been described with autoantibodies to the beta4 subunit of alpha6beta4 integrin. We describe a patient with extensive disease of ocular, oral, pharyngeal, laryngeal and genital mucous membranes that healed with scarring of conjunctivae. IgG autoantibodies bound to the dermal-epidermal junction on direct immunofluorescence (IF) microscopy and to the epidermal side of 1 mol L(-1) NaCl-split skin on indirect IF microscopy. Our patient's circulating IgG recognized a 205-kDa protein in extracts of 293T cells transfected with the beta4 subunit of alpha6beta4 integrin and in the cell extract of DJM-1 cells. Our patient's IgG and IgA autoantibodies also reacted with full-length BP180 derived from epidermal extracts and the ectodomain of BP180 (LAD-1) derived from culture supernatant of keratinocytes. In addition, a weak IgG reaction with BP230 was noted. The disease rapidly responded to dexamethasone-cyclophosphamide pulse therapy, and immunoblot reactivity to both beta4 integrin and BP180 decreased according to disease activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899157     DOI: 10.1046/j.1365-2133.2001.04543.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

Authors:  I Elser; D Selimovic; T Ruzicka; A Kuhn; M Megahed
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm.

Authors:  Akiko Imanishi; Hisayoshi Imanishi; Sho Hiroyasu; Toshiyuki Ozawa; Hiroshi Koga; Norito Ishii; Yasuo Kitajima; Takashi Hashimoto; Daisuke Tsuruta
Journal:  Med Mol Morphol       Date:  2015-12-10       Impact factor: 2.309

3.  Diagnosis and clinical severity markers of bullous pemphigoid.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  F1000 Med Rep       Date:  2009-02-24

4.  Mucous membranepemphigoid in two half-sisters. The potential roles of autoantibodies to β4 integrin subunits and HLA-DQβ1*0301.

Authors:  Diogo Fabris Rabelo; Tegan Nguyen; Brooke Ann Caufield; Abdul Razzaque Ahmed
Journal:  J Dermatol Case Rep       Date:  2014-03-31

5.  Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction.

Authors:  Valerio Russo; Theo Klein; Darielle J Lim; Nestor Solis; Yoan Machado; Sho Hiroyasu; Layla Nabai; Yue Shen; Matthew R Zeglinski; Hongyan Zhao; Cameron P Oram; Peter A Lennox; Nancy Van Laeken; Nick J Carr; Richard I Crawford; Claus-Werner Franzke; Christopher M Overall; David J Granville
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

Review 6.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

7.  Expression of selected integrins and selectins in bullous pemphigoid.

Authors:  Agnieszka Zebrowska; Anna Sysa-Jedrzejowska; Małgorzata Wagrowska-Danilewicz; Ewa Joss-Wichman; Anna Erkiert-Polguj; Elzbieta Waszczykowska
Journal:  Mediators Inflamm       Date:  2007-04-02       Impact factor: 4.711

Review 8.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

9.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.